Colchicine for stroke prevention in patients with coronary artery disease: a systematic review and meta‐analysis

Although clinical trials suggest that colchicine may reduce the risk of vascular events in patients with a history of coronary artery disease, its effect on the prevention of cerebrovascular events still remains unclear.

[1]  R. Diaz,et al.  Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction. , 2019, The New England journal of medicine.

[2]  S. Patel,et al.  Colchicine for Stroke Prevention: A Systematic Review and Meta-analysis. , 2019, Clinical therapeutics.

[3]  G. Tsivgoulis,et al.  Anti-inflammatory approaches to ischaemic stroke prevention , 2017, Journal of Neurology, Neurosurgery, and Psychiatry.

[4]  C. Alves,et al.  Number needed to treat (NNT) in clinical literature: an appraisal , 2017, BMC Medicine.

[5]  P. Ridker.  How Common Is Residual Inflammatory Risk? , 2017, Circulation research.

[6]  L. Hemkens,et al.  Cardiovascular effects and safety of long-term colchicine treatment: Cochrane review and meta-analysis , 2016, Heart.

[7]  L. Hemkens,et al.  Colchicine for prevention of cardiovascular events. , 2016, The Cochrane database of systematic reviews.

[8]  G. Mccarthy,et al.  Colchicine: New Insights to an Old Drug , 2015, American journal of therapeutics.

[9]  K. Hirata,et al.  Anti-inflammatory and immune-modulatory therapies for preventing atherosclerotic cardiovascular disease. , 2015, Journal of cardiology.

[10]  M. Cleman,et al.  Anti-inflammatory treatment with colchicine in stable chronic heart failure: a prospective, randomized study. , 2014, JACC. Heart failure.

[11]  M. Cleman,et al.  Colchicine treatment for the prevention of bare-metal stent restenosis in diabetic patients. , 2013, Journal of the American College of Cardiology.

[12]  J. Eikelboom,et al.  Low-dose colchicine for secondary prevention of cardiovascular disease. , 2013, Journal of the American College of Cardiology.

[13]  P. Libby,et al.  Progress and challenges in translating the biology of atherosclerosis , 2011, Nature.

[14]  J. Eikelboom,et al.  Effect of colchicine compared with placebo on high sensitivity C-reactive protein in patients with acute coronary syndrome or acute stroke: a pilot randomized controlled trial , 2011, Journal of Thrombosis and Thrombolysis.